It has been reported that ionizing radiation stimulates DR4 and DR5 expression in multiple tumor cell lines in vitro [19,20,21,22,23], as well as decoy receptors [24,25], but this cannot explain the limitations of the combination of radiotherapy with TRAIL in clinical trials. The gene discussed is TNFSF10; the disease is neoplasm.